ArisGlobal

Announcement: E2B(R3) compliance with ArisGlobal’s Total Safety v7


Total Safety v7 is ArisGlobal’s comprehensive Clinical Safety and Pharmacovigilance Solution Suite. This system provides extensive capabilities to support collection, assessment and distribution of both clinical and post-marketing Adverse Event and Adverse Reaction Reports.

Get answers to the evolving E2B(R3) regulation by attending this complimentary webinar. Please join Christian Moorman, Senior Director, Leading Practices to understand how we are upgrading our products to help our customers achieve E2B(R3)compliance. Also learn how this simplified version upgrade can be done efficiently in a cost-effective manner.

Click on the link below to view the datasheet

Announcement: E2B(R3) compliance with ArisGlobal’s Total Safety v7